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Abstract
Dieulafoy’s lesion (DL) is a rare source of gastrointestinal tract bleeding that may occur at any site in the gastrointestinal
tract and may be difﬁcult to detect by endoscopy. DL is characterized by a large, tortuous arteriole in the submucosa. This is
a case of duodenal DL that is detected and treated by endoscopy. This article is part of an expert video encyclopedia.
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Video Related to this Article
Materials
• GIF H-180J; Olympus Medical Systems Europe, Hamburg,
Germany.
• Metal clip
J Quick Clip; Olympus Medical Systems Europe, Ham-
burg, Germany.
J Long Clip (Olympus HX - 610 - 090L); Olympus med-
ical Europe, Hamburg, Germany.
J Clip - applicator (Olympus HX - 110 UR); Olympus
medical Europe, Hamburg, Germany.
• Water jet irrigation system: Olympus OFP; Olympus
Medical Systems Europe, Hamburg, Germany.
Background and Endoscopic Procedures
Dieulafoy’s lesion (DL) is a rare reason for intestinal bleeding
that may occur at any site in the gastrointestinal tract and is
responsible for up to 4% of acute upper gastrointestinal
bleeding cases.1,2 DL is characterized by a congenital single
large, tortuous arteriole in the intestinal submucosa, which
may not have undergone normal branching and possesses a
caliber of 1–5 mm, which is more than 10 times the normal
diameter of mucosal capillaries. It was named after Paul
Georges Dieulafoy (1839–1911), a French physician who
described this phenomenon for the ﬁrst time in 1898.
The lesion bleeds into the gastrointestinal tract through a
minute defect in the mucosa, which might have been pro-
voked by protrusion of the pulsatile arteriole. The site of this
lesion is most often found in the stomach and less frequently
in the duodenum.1
For treating DL, endoscopy is a safe and an effective method.
Several endoscopic techniques have been described, including
application of hemoclips, injection therapy, thermal probes,
laser therapy, and endoscopic band ligation. Permanent
hemostasis is achieved in more than 90% cases with endoscopic
therapy. Mechanical methods of endoscopic hemostasis provide
permanent hemostasis in up to 100% of cases, and rebleeding
rates were signiﬁcantly lower with injection therapy.3–7
Key Learning Points/Tips and Tricks
• Hemoclipping might be superior to injection therapy in DL.
• The initial use of injected epinephrine may slow down
the blood ﬂow and allow for better visualization of the
lesion in some cases, facilitating successful treatment with
hemoclipping.
Complications and Risk Factors
Complications of DL of the duodenum are similar to other
causes of intestinal bleeding, i.e., hemodynamic compromise,
low blood pressure, and low cardiac output. Older patients are
especially at risk of cardiac decompensation. Perforation is a
very rare but life-threatening complication.
Endoscopic therapy might cause infection or – very rarely –
perforation. In the case of using endoscopic band ligation to
stop bleeding from DL, a newly formed ulcer caused by the
band ligation may itself cause bleeding.
Risk factors for DL are Helicobacter pylori infection, gas-
trinoma, and chewing bubble gum in an excessive way causing
increased production of gastric acid. Chronic high blood
pressure is thought to promote the development of large,
tortuous arterioles in the submucosa. Moreover, Crohn’s dis-
ease may be a risk factor for developing DL, and excessive use
of tobacco, alcohol, and medications such as nonsteroidal
This article is part of an expert video encyclopedia. Click here for the full
Table of Contents.
Video Journal and Encyclopedia of GI Endoscopy
Video available to view or download at doi:10.1016/S2212- 
0971(13)70091-8
http://dx.doi.org/10.1016/S2212-0971(13)70091-8 215
Open access under CC BY-NC-ND license.
anti-inﬂammatory drugs, especially taken together with
steroids, are referred as risk factors.
Alternatives
• Fibrin glue injection, thermal/heater probes, argon plasma
coagulation, and bipolar electrocoagulation are alternatives
to hemoclipping but might be less readily available at some
centers.
• Laser therapy and endoscopic band ligation might be re-
garded as second-line interventions.
• Surgery might be necessary in rare cases when endoscopic
treatment fails.
Scripted Voiceover
Time
(min:sec)
Voiceover text
0:01 At the transition of the ﬁrst to second portion of the
duodenum, there is a pulsatile bleeding detected by
upper gastrointestinal tract endoscopy.
0:14 Repeatedly ﬂushing the actively bleeding lesion with water
helps identify the exact localization of the bleeding
source. There is only a minute mucosal defect at
this Dieulafoy’s lesion, which might be difﬁcult to
detect by endoscopy, in case the lesion does not actively
bleed.
0:50 A hemoclip is advanced through the working channel of
the endoscope and repeated ﬂushing through an
auxiliary water channel helps to place the clip correctly.
Sucking remnant blood and water from the lumen
additionally improves visibility of the lesion.
1:22 In case a ﬁrst hemoclip only reduces blood ﬂow, a second
or even third clip may be useful to completely and
permanently stop the bleeding.
2:00 Final inspection of the treatment result, after ample
cleansing of the area of interest with injecting water,
conﬁrms complete termination of active bleeding.
There is a very low probability of recurrence when
applying mechanical endoscopic hemostasis in
Dieulafoy’s lesion.
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